NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
6 hedge funds and large institutions have $6.65K invested in NRX Pharmaceuticals Warrant in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
134% more capital invested
Capital invested by funds: $2.84K → $6.65K (+$3.81K)
50% more funds holding
Funds holding: 4 → 6 (+2)
0.1% more ownership
Funds ownership: 0.02% → 0.12% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$5.18K |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
+$4.89K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$2.94K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$1.6K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Truist Financial
Charlotte,
North Carolina
| $2.34K | +$4.89K | +38,965 | New |
|
|
VF
2
Virtu Financial
New York
| $2K | +$5.18K | +41,283 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $1.41K | +$2.94K | +23,412 | +33,930% |
|
|
WAM
4
Wolverine Asset Management
Chicago,
Illinois
| $895 | +$1.6K | +12,735 | +590% |
|
|
5
Bank of America
Charlotte,
North Carolina
| $6 | +$12 | +95 | New |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1 | – | – | – |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$2.42K | -13,436 | Closed |
|
NRXPW Hedge Fund Activity: Q2 2024 in Review
6 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q2 2024, worth a combined $6.65K — up 134% from $2.84K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NRXPW positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $5.18K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.42K sold.
- 6 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q2 2024, up from 4 in Q1 2024.
- Funds reported $6.65K of NRX Pharmaceuticals Warrant stock for Q2 2024, up 134% quarter-over-quarter.
- 3 funds opened new NRX Pharmaceuticals Warrant positions in Q2 2024 and 1 closed out, a net change of +2 holders.
- The largest NRX Pharmaceuticals Warrant buyer in Q2 2024 was Virtu Financial, an estimated $5.18K added.
- The largest NRX Pharmaceuticals Warrant seller in Q2 2024 was Susquehanna International Group, an estimated $2.42K sold.
Based on aggregated 13F filings for Q2 2024.